Our mission - is to facilitate the transition of the Russian pharmaceutical market to develop into mature, be a guide on the course of development of the potential of all the pharmaceutical market participants, thereby improving the quality of life for the end user and society in general. Despite the relatively high susceptibility to Russia's external economic and financial risks, imbalances in the domestic policy and great social disparities, the pharmaceutical market in Russia has had a stable positive growth for the last few years.
In the first four months of 2019, drugs manufactured in the EAEU were delivered to Russia in the amount of 3.6 billion rubles, which is 37.8% more than in the same period last year. In real terms, the volume of imports amounted to 85.4 million packs, which is 46.3% more than last year.
From May 20 to May 24, the 2nd National Pharmaceutical Award SmartPharma® Awards was held. To win claimed 64 drugs 50 pharmaceutical companies. 28,000 pharmacy specialists were invited to vote - members of the Smartpharma professional community.